Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma shows promise for treating erectile dysfunction, but more research is needed.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Stopping finasteride can lead to lasting sexual and psychological issues.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Finasteride doesn't negatively affect sexual function in Indian men with hair loss.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Early hair loss may indicate prostate issues.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

Men with urinary symptoms are more likely to have erectile dysfunction, and there's a debate about research methods and authorship ethics.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.